Omeros Corporation (OMER) Financial Statements (2026 and earlier)

Company Profile

Business Address 201 ELLIOTT AVENUE WEST
SEATTLE, WA 98119
State of Incorp. WA
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:171,80090,100171,800194,900157,300134,953
Cash and cash equivalent9,6603,4007,10511,009100,80810,501
Short-term investments162,14486,732164,743183,90956,458124,452
Other undisclosed cash, cash equivalents, and short-term investments (4)(32)(48)(18)34 
Receivables10,9177,7398,096213,22138,1553,841
Inventory, net of allowances, customer advances and progress billings     1,355
Inventory     1,355
Other undisclosed current assets32,95036,28138,00235,11552,43411,136
Total current assets:215,667134,120217,898443,236247,889151,285
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization 1,2872,025 9451,009 
Operating lease, right-of-use asset10,70814,96118,63121,76228,27625,526
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization1,7682,6781,950  10,198
Prepaid expense     67625
Restricted cash and investments1,0541,0541,0541,0541,0541,055
Other undisclosed noncurrent assets95,148122,241138,736123,972140,973(7,647)
Total noncurrent assets:109,965142,959160,371147,733171,37929,757
TOTAL ASSETS:325,632277,079378,269590,969419,268181,042
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34,15231,91039,58036,54046,83432,954
Taxes payable300 
Accounts payable4,7645,9057,7125,98913,4004,199
Accrued liabilities29,38826,00531,86830,55133,13428,755
Debt 17,56621,732 94,8036481,042
Other undisclosed current liabilities26,34425,88413,7365,0404,3072,740
Total current liabilities:78,06279,52653,316136,38351,78936,736
Noncurrent Liabilities
Long-term debt and lease obligation52,085167,825213,155221,361342,584236,288
Long-term debt, excluding current maturities51,364166,583213,155220,906313,458236,288
Finance lease, liability 7211,242 455315 
Liabilities, other than long-term debt12,22616,7252,08822,4151,115 
Accounts payable and accrued liabilities5,7024,5012,0884441,115 
Operating lease, liability 6,52412,224 21,97128,811 
Derivative instruments and hedges, liabilities      
Total noncurrent liabilities:64,311184,550215,243243,776343,699236,288
Total liabilities:142,373264,076268,559380,159395,488273,024
Equity
Equity, attributable to parent(121,231)(182,609)(24,983)85,68423,780(120,752)
Common stock716580611628626616
Additional paid in capital791,748727,156727,936720,773706,288751,304
Accumulated deficit(913,695)(910,345)(753,530)(635,717)(683,134)(872,672)
Total equity:(121,231)(182,609)(24,983)85,68423,780(120,752)
Other undisclosed liabilities and equity304,490195,612134,693125,126 28,770
TOTAL LIABILITIES AND EQUITY:325,632277,079378,269590,969419,268181,042

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues8921,5891,5001,7551,77673,813
Sublease income8921,5891,5001,7551,7761,300
Cost of revenue
(Cost of Product and Service Sold)
     (902)
Gross profit:8921,5891,5001,7551,77672,911
Operating expenses(122,796)(169,258)(164,530)(163,389)(173,617)(183,512)
Other undisclosed operating loss(892)(1,589)(1,500)(1,755)(1,776) 
Operating loss:(122,796)(169,258)(164,530)(163,389)(173,617)(110,601)
Nonoperating income 237,594   1,740654
Investment income, nonoperating 237,594     
Other nonoperating income     1,740654
Interest and debt expense960(24,675)(26,732)(22,702)(19,669)(40,125)
Other undisclosed income from continuing operations before equity method investments, income taxes      
Income (loss) from continuing operations before equity method investments, income taxes:115,758(193,933)(191,262)(186,091)(191,546)(150,072)
Other undisclosed income (loss) from continuing operations before income taxes(118,554)  4,062  
Income (loss) from continuing operations before income taxes:(2,796)(193,933)(191,262)(182,029)(191,546)(150,072)
Income tax expense (benefit)(2,012)    12,011
Other undisclosed loss from continuing operations      
Income (loss) from continuing operations:(4,808)(193,933)(191,262)(182,029)(191,546)(138,061)
Loss before gain (loss) on sale of properties:(191,546)(138,061)
Loss from discontinued operations    (3,952)  
Other undisclosed net income    233,398385,781 
Net income (loss):(4,808)(193,933)(191,262)47,417194,235(138,061)
Other undisclosed net income attributable to parent1,45837,11873,449   
Net income (loss) available to common stockholders, diluted:(3,350)(156,815)(117,813)47,417194,235(138,061)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):(4,808)(193,933)(191,262)47,417194,235(138,061)
Comprehensive income (loss), net of tax, attributable to parent:(4,808)(193,933)(191,262)47,417194,235(138,061)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: